Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study

Clinical trial NCT05135650 · TERMINATED

Trial details

NCT number: NCT05135650
Sponsor: Fred Hutchinson Cancer Center
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

COVID-19 Infection Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm

Start date: 2022-01-25
Primary completion: 2022-10-18
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.